Angelini Pharma launches crowdsourcing project to tackle drug-resistant epilepsy

Why the FDA must delete its statement that people are not horses (or cows), referring to ivermectin use

Testing directly on a diseased human cell is more efficient and more accurate, but ambition is lacking

We ask an expert from Elsevier about the future of digital tech in drug discovery.

The blood–brain barrier is a problem for most Alzheimer’s disease therapeutics, but ultrasound can help.

In this video interview, Courtney Silverthorn explains the inspiration behind a free regulatory playbook for gene therapy manufacturers.

Production records written using erasable markers, use of expired raw materials, and more.

Day 3 closes out with sessions on drug delivery devices

Lipid nanoparticles are a cornerstone of mRNA therapeutics. For manufacturing, will you choose stainless steel or single-use?

Looking for a guide to day 2 of the show? We’ve got you covered.